Showing results (121-130 of 1,231) with videos related to

Sort By:
Pageof 124
Jac-Antimicrobial Resistance|February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
Jac-Antimicrobial Resistance|February 14, 2022
The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing SurveyRodney James, Yoshiko Nakamachi, Andrew Morris, et al.
Jac-Antimicrobial Resistance|October 4, 2021
Oxacillin plus ertapenem combination therapy leads to rapid blood culture clearance and positive outcomes among patients with persistent MSSA bacteraemia: a case seriesSami El-Dalati, Sanjay Sridaran, Marissa Uricchio, et al.
Jac-Antimicrobial Resistance|November 1, 2021
Feasibility of a community pharmacy antimicrobial stewardship intervention (PAMSI): an innovative approach to improve patients' understanding of their antibioticsRosalie Allison, Sarah Chapman, Philip Howard, et al.
Jac-Antimicrobial Resistance|March 21, 2022
Antibiotic resistance: calling time on the 'silent pandemic'Marc Mendelson, Michael Sharland, Mirfin Mpundu
Jac-Antimicrobial Resistance|April 25, 2022
Therapeutic drug monitoring of cefepime in a non-critically ill population: retrospective assessment and potential role for model-based dosingVéronique Suttels, Pascal André, Yann Thoma, et al.
Jac-Antimicrobial Resistance|April 21, 2022
Exploring barriers to guideline implementation for prescription of surgical antibiotic prophylaxis in NigeriaCaroline E Wood, Susanne Luedtke, Anwar Musah, et al.
Jac-Antimicrobial Resistance|March 30, 2022
Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against Category A and B priority pathogensJason E Cummings, Zaid Abdo, Richard A Slayden
Jac-Antimicrobial Resistance|October 27, 2021
CON: Procalcitonin does not have clinical utility in children with community-acquired pneumoniaRitu Banerjee
Jac-Antimicrobial Resistance|October 22, 2021
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapyConor Jamieson, Felicity Drummond, Tim Hills, et al.
Pageof 124